Recent developments in therapy for HER2+ and HER2- Non-small cell lung cancer
Lung cancer kills more people worldwide than breast, prostate, colorectal, and brain cancers combined.1 Non-small cell lung cancer (NSCLC)...
MDforLives
Advances in our understanding of rosacea will help patients
Rosacea is a skin condition that affects the face, specifically the forehead, nose, cheeks, and chin.1,2 Patients often require...
Ovarian Cancer: The new normal- Standards of care before, during and after the pandemic – Part 1
COVID-19 is a severe acute respiratory syndrome that has blighted the world over the last year. The World Health...
Current and future paradigms in the management of Esophageal Cancer
In data released by GLOBOCAN 2020, stomach Cancer is the 5th biggest cancer in the world, with esophageal Cancer...
SGLT2 inhibitors and GLP1 agonists in Diabetes Type 2
Over the last few years, there have been significant breakthroughs in the management of Type 2 diabetes (T2D). Sodium–glucose...
FDA Approves Pradaxa (Dabigatran Etexilate), the First Oral Anticoagulant for Children
The Food and Drug Administration approves Boehringer Ingelheim’s Pradaxa (dabigatran etexilate) oral pellets to treat venous thromboembolism (VTE) in children aged 3...
Early-Life Antibiotic Exposure, Gut Microbiome, and Neurodevelopment
Over the past few decades, there has been a dramatic increase in the incidence of childhood neurodevelopmental disorders such...
The changing landscape of HER2-positive Breast Cancer
For several years we have approached a ‘standard of care’ (SOC) for the treatment of metastatic HER2-positive breast cancer....
Beware cancer cells – the Oncolytic virus is coming for you!
The field of immunology is transforming the landscape for cancer patients. When you can get a T-cell into the...
Biomarker for Early Detection of Pancreatic Cancer
Pancreatic cancer is one of the leading causes of cancer-related death. Despite advanced treatment regimens, the 5-year survival rate...